Will DGCI ban on drug ingredients from China hurt the Pharma industry?

Will DGCI ban on drug ingredients from China hurt the Pharma industry?

The ban on the import of APIs from China may lead to possible shortages of antibiotics, and anti-br diabetes, anti-psychotic and antacid drugs, say pharma lobby groupsbr Subscribe Now For Latest Updates-


User: Mint

Views: 1

Uploaded: 2018-02-16

Duration: 03:25

Your Page Title